Close Menu

NEW YORK (GenomeWeb) – Two letters to the editor of the New England Journal of Medicine have pointed out possible flaws or omissions in a recent paper that suggested that a gene test could guide breast cancer treatment decisions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.